Autolus Ltd.

Autolus Ltd.

Autolus Ltd.

Autolus is a private biopharmaceutical company, focused on the development and commercialisation of engineered Tcell immunotherapy products with extreme efficacy in the treatment of lifethreatening cancers..
Type
B2b
Founded
2014
Raised
$285.6M
Follow us
Alexa global traffic share
Latest funding Show all
$150,000,000
IPO - 2018
Team Size
10+
Employees
the home of AI info

Autolus Therapeutics plc (AUTL)'s Financial Results Comparing With Minerva Neurosciences Inc ...

$150,000,000 IPO
PE HUB

Autolus goes public

Stock markets Privacy
PE HUB

Autolus sets IPO pricing terms

Stock markets Privacy
PE HUB

Autolus taps Oakley as SVP and CFO

PE HUB

UK biotech firm Autolus joins CAR-T rush with Nasdaq IPO filing: Reuters

Health